Omeprazol Stada (Omeprazole)

Omeprazole, the active ingredient in Omeprazol Stada, is a proton pump inhibitor presented as a tablet for oral use. It reduces gastric acid production and is employed in the management of acid‑related gastrointestinal disorders in adults, including gastro‑esophageal reflux disease, peptic ulcer disease and related conditions.

GNH USA supplies Omeprazol Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across markets.

Omeprazole acts on the gastric proton pump to lower acid secretion, making it useful for several acid‑related conditions.

- Gastro‑esophageal reflux disease (GERD): reduces symptoms and promotes healing of esophageal irritation. - Peptic ulcer disease: facilitates ulcer healing by decreasing gastric acidity. - Helicobacter pylori eradication regimens: enhances the effectiveness of antibiotic therapy. - Erosive esophagitis: promotes mucosal recovery and symptom relief.

Common Side Effects: - Headache: mild to moderate intensity. - Abdominal pain: discomfort in the upper abdomen. - Diarrhea: loose stools occurring intermittently. - Nausea: feeling of sickness without vomiting. - Flatulence: increased gas production. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis risk with prolonged use. - Severe allergic reactions (anaphylaxis): rash, swelling, breathing difficulty. - Stevens‑Johnson syndrome/toxic epidermal necrolysis: rare skin reactions. - Elevated liver enzymes: potential hepatic injury. - Hypomagnesemia: low magnesium levels with long‑term therapy. - Interstitial nephritis: inflammation of kidney tissue.

Before initiating therapy, consider the following precautions.

- Assess renal function: dose adjustment may be needed in severe impairment. - Monitor for infection: prolonged use can increase risk of C. difficile colitis. - Avoid in known hypersensitivity: discontinue if allergic reactions occur. - Use with caution in osteoporosis: long‑term therapy may affect calcium absorption. - Pregnancy and lactation: weigh benefits against potential risks and consult a healthcare provider. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Omeprazole may interact with several medicines; awareness of interaction severity is essential.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, increasing cardiovascular risk. - Atazanavir, nelfinavir: decreased antiviral plasma concentrations. - Methotrexate: increased toxicity due to reduced clearance.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, requiring closer monitoring. - Digoxin: may raise serum digoxin levels. - Diazepam: potential increase in sedation due to higher plasma concentrations.